Saaketa Consultants LTD

Particulars

Mar 26

Mar 25

Mar 24

Mar 23

Mar 22

Months

Source Of Info (AR = Annual Report, PR = Press Release)

FaceValue

10.00

INCOME

Revenue From Operations [Net]

176.23

166.95

383.99

345.72

255.38

Total Operating Revenues

176.23

166.95

383.99

345.72

255.38

Other Income

3.06

3.04

1.09

0.48

0.21

Total Revenue

179.29

170.00

385.08

346.20

255.58

EXPENSES

Purchase Of Stock-In Trade

124.59

87.12

228.86

232.22

183.56

Changes In Inventories Of FG,WIP And Stock-In Trade

8.66

5.16

0.99

0.48

-15.41

Employee Benefit Expenses

5.63

5.06

6.90

3.63

3.59

Finance Costs

1.01

0.60

0.88

0.29

0.14

Depreciation And Amortisation Expenses

0.46

0.51

0.32

0.29

0.38

Other Expenses

35.51

66.50

134.46

102.09

77.19

Total Expenses

175.86

164.94

372.40

339.00

249.45

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax

3.43

5.05

12.68

7.20

6.13

Profit/Loss Before Tax

3.43

5.05

12.68

7.20

6.13

Tax Expenses-Continued Operations

Current Tax

0.87

1.32

3.86

1.90

1.82

Deferred Tax

0.00

-0.15

-0.49

-0.01

-0.06

Total Tax Expenses

0.87

1.16

3.37

1.89

1.76

Profit/Loss After Tax And Before ExtraOrdinary Items

2.56

3.89

9.31

5.31

4.37

Profit/Loss From Continuing Operations

2.56

3.89

9.31

5.31

4.37

Profit/Loss For The Period

2.56

3.89

9.31

5.31

4.37

OTHER INFORMATION

EARNINGS PER SHARE

Basic EPS (Rs.)

1.69

2.57

8.38

4.78

3.95

Diluted EPS (Rs.)

1.67

2.53

8.38

4.78

3.95

Market

Insurance

IPO

Quick Links

Other Links

Stocks

Others

Mutual Fund

OTHERS

I. PLEASE PROVIDE NOMINATION, IF DONE IGNORE THE SAME. Refer Communique DP2024-317 dated June 11, 2024 | II. Attention Investors : Prevent Unauthorized transactions in your Trading /Demat account. Update your mobile number/email IDs with your stock broker/ Depository Participant. Receive information of your transactions directly from Exchange on your Mobile/email at the end of the day & Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day .......... Issued in the interest of investors. | III. Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | IV. Attention Investors : No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor's account. | V. KIND ATTENTION ACCOUNT HOLDERS : Kindly submit the Details of Aadhar number along with copy of Aadhar Card. | VI. Attention Investors : 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. | 3. Pay 20% upfront margin of the transaction value to trade in the cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors

To freeze or block online access of your account, please click here

Investor Grievance: Investors may contact us at cjr.saaketa@gmail.com for any requirements

SAAKETA INVESTMENT SERVICES LIMITED : INZ000179131, CDSL: IN-DP-CDSL-299-2005 | CIN No: L74140TG1992PLC014483
SAAKETA COMMODITIES PVT LTD MCX : INZ000081835 | CIN Number : U67120TG2005PTC046929

Designed, developed and content provided by